This is a Validated Antibody Database (VAD) review about human ICOS, based on 77 published articles (read how Labome selects the articles), using ICOS antibody in all methods. It is aimed to help Labome visitors find the most suited ICOS antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
ICOS synonym: AILIM; CD278; CVID1

BioLegend
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; 0.2 mg/ml; loading ...; fig 2e
BioLegend ICOS antibody (BioLegend, 313510) was used in flow cytometry on mouse samples at 0.2 mg/ml (fig 2e). Sci Rep (2021) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; 1:200; fig 1h
BioLegend ICOS antibody (Biolegend, C398.4A) was used in flow cytometry on mouse samples at 1:200 (fig 1h). Front Immunol (2021) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig s4a
BioLegend ICOS antibody (Biolegend, C398.4A) was used in flow cytometry on mouse samples (fig s4a). Proc Natl Acad Sci U S A (2021) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; 1:100; fig 1e
BioLegend ICOS antibody (BioLegend, 313520) was used in flow cytometry on mouse samples at 1:100 (fig 1e). elife (2021) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig 3c
BioLegend ICOS antibody (Biolegend, 313520) was used in flow cytometry on mouse samples (fig 3c). Nat Commun (2021) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; 1:200; loading ...; fig 3d
BioLegend ICOS antibody (BioLegend, C398.4A) was used in flow cytometry on mouse samples at 1:200 (fig 3d). elife (2020) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...
BioLegend ICOS antibody (BioLegend, 313538) was used in flow cytometry on mouse samples . Cell (2020) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; 1:100; loading ...; fig 1a, 7s1a
BioLegend ICOS antibody (Biolegend, 313518) was used in flow cytometry on mouse samples at 1:100 (fig 1a, 7s1a). elife (2020) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; human; loading ...; fig 2s2c
BioLegend ICOS antibody (Biolegend, 313524) was used in flow cytometry on human samples (fig 2s2c). elife (2020) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig 6d
BioLegend ICOS antibody (Biolegend, C398.4A) was used in flow cytometry on mouse samples (fig 6d). elife (2020) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; human; loading ...; fig s12a
BioLegend ICOS antibody (Biolegend, C398.4A) was used in flow cytometry on human samples (fig s12a). Nat Commun (2020) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig s1a
BioLegend ICOS antibody (Biolegend, C398.4A) was used in flow cytometry on mouse samples (fig s1a). BMC Immunol (2019) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig 1d
BioLegend ICOS antibody (Biolegend, 313508) was used in flow cytometry on mouse samples (fig 1d). Cell Rep (2019) ncbi
hamsters monoclonal (C398.4A)
  • other; human; loading ...; fig 7s1b
BioLegend ICOS antibody (BioLegend, C398.4A) was used in other on human samples (fig 7s1b). elife (2019) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; human; loading ...; fig 1b
BioLegend ICOS antibody (Biolegend, 313525) was used in flow cytometry on human samples (fig 1b). Cell Mol Gastroenterol Hepatol (2020) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig 5a
BioLegend ICOS antibody (Biolegend, C398.4A) was used in flow cytometry on mouse samples (fig 5a). Front Immunol (2019) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig s16b
BioLegend ICOS antibody (Biolegend, C398.4A) was used in flow cytometry on mouse samples (fig s16b). Science (2019) ncbi
hamsters monoclonal (C398.4A)
  • mass cytometry; human; loading ...; fig 2b
BioLegend ICOS antibody (Biolegend, 313502) was used in mass cytometry on human samples (fig 2b). Cell (2019) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig s5l
BioLegend ICOS antibody (Biolegend, 313510) was used in flow cytometry on mouse samples (fig s5l). Cell (2019) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend ICOS antibody (BioLegend, C398.4A) was used in flow cytometry on mouse samples (fig 1a). J Exp Med (2019) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; rat; loading ...; fig 15a
BioLegend ICOS antibody (BioLegend, C398.4A) was used in flow cytometry on rat samples (fig 15a). PLoS ONE (2019) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend ICOS antibody (BioLegend, 313529) was used in flow cytometry on mouse samples (fig 1c). Cell (2019) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; fig s3c
  • flow cytometry; rat; fig s3c
  • flow cytometry; human; loading ...; fig s3c
BioLegend ICOS antibody (BioLegend, 313540) was used in flow cytometry on mouse samples (fig s3c), in flow cytometry on rat samples (fig s3c) and in flow cytometry on human samples (fig s3c). Immunity (2018) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; 1:400; loading ...; fig 4d
BioLegend ICOS antibody (Biolegend, C398.4A) was used in flow cytometry on mouse samples at 1:400 (fig 4d). Nat Commun (2018) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; human; loading ...; fig s1a
BioLegend ICOS antibody (BioLegend, C398.4A) was used in flow cytometry on human samples (fig s1a). J Clin Invest (2018) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; 1:200; loading ...; fig 2c
BioLegend ICOS antibody (Biolegend, C398.4A) was used in flow cytometry on mouse samples at 1:200 (fig 2c). Nat Commun (2017) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig s1h
In order to investigate the role of IL-4Ralpha-mediated macrophage activation promote in lung and liver wound repair, BioLegend ICOS antibody (BioLegend, C398.4A) was used in flow cytometry on mouse samples (fig s1h). Science (2017) ncbi
hamsters monoclonal (C398.4A)
  • mass cytometry; human; fig s8
BioLegend ICOS antibody (BioLegend, 313502) was used in mass cytometry on human samples (fig s8). Nature (2017) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; human; loading ...; fig s2a
BioLegend ICOS antibody (BioLegend, C.398.4A) was used in flow cytometry on human samples (fig s2a). JCI Insight (2017) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; human
  • flow cytometry; mouse; loading ...; fig 2b
In order to assess whether human T-cell leukemia virus type 1 bZIP factor enhances the proliferation of expressing T cells after stimulation via the T-cell receptor, BioLegend ICOS antibody (BioLegend, C398.4A) was used in flow cytometry on human samples and in flow cytometry on mouse samples (fig 2b). PLoS Pathog (2017) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; human; loading ...; fig 2a
In order to study the contribution of T follicular helper cells to islet autoimmunity, BioLegend ICOS antibody (Biolegend, C398.4A) was used in flow cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2016) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...
In order to study the effect of IL-13 and IL-33 pathways in dysregulated type 2 inflammation., BioLegend ICOS antibody (Biolegend, C398.4A) was used in flow cytometry on mouse samples . J Allergy Clin Immunol (2017) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig st1
In order to determine the contribution of IL-33 and ST2 to eosinophil homeostasis, BioLegend ICOS antibody (BioLegend, C398.4A) was used in flow cytometry on mouse samples (fig st1). J Immunol (2016) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig 6d
In order to investigate allergic responses to food allergens in WASP-deficient animals, BioLegend ICOS antibody (Biolegend, C398.4A) was used in flow cytometry on mouse samples (fig 6d). J Clin Invest (2016) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; 1:200; loading ...; tbl s2
In order to identify and characterize follicular cytotoxic T cells, BioLegend ICOS antibody (Biolegend, C398.4A) was used in flow cytometry on mouse samples at 1:200 (tbl s2). Nat Immunol (2016) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; rhesus macaque; loading ...
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, BioLegend ICOS antibody (BioLegend, 313520) was used in flow cytometry on rhesus macaque samples . Nat Med (2016) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; human; loading ...; fig 1b
BioLegend ICOS antibody (BioLegend, C398.4A) was used in flow cytometry on human samples (fig 1b). Nat Immunol (2016) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; human; loading ...; fig 3
In order to study the pharmacologic inhibition of PI3K and MEK pathways in mixed cultures of human mononuclear cells., BioLegend ICOS antibody (BioLegend, C398.4A) was used in flow cytometry on human samples (fig 3). Am J Transplant (2016) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; loading ...; fig 4c
In order to propose that neuronal autoimmunity is a pathogenic feature of type 1 diabetes, BioLegend ICOS antibody (Biolegend, C398.4A) was used in flow cytometry on mouse samples (fig 4c). Diabetes (2016) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; human
In order to evaluate the promotion of B cell activation and CXCR4 downregulation by CD161 and LLT1 expression in human germinal centers, BioLegend ICOS antibody (BioLegend, C398.4A) was used in flow cytometry on human samples . J Immunol (2016) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; African green monkey; fig 1
In order to study lymph node-resident simian immunodeficiency virus env-specific T follicular helper cells due to vaccine induction in Rhesus Macaques, BioLegend ICOS antibody (Biolegend, C398.4A) was used in flow cytometry on African green monkey samples (fig 1). J Immunol (2016) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse; fig s4
BioLegend ICOS antibody (biolegend, C398.4A) was used in flow cytometry on mouse samples (fig s4). Theranostics (2015) ncbi
hamsters monoclonal (C398.4A)
BioLegend ICOS antibody (BioLegend, 313510) was used . Nat Commun (2015) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; mouse
BioLegend ICOS antibody (BioLegend, 313516) was used in flow cytometry on mouse samples . J Leukoc Biol (2015) ncbi
hamsters monoclonal (C398.4A)
  • blocking or activating experiments; mouse; 20 ug/ml; fig 7
BioLegend ICOS antibody (Biolegend, C398.4A) was used in blocking or activating experiments on mouse samples at 20 ug/ml (fig 7). J Immunol (2015) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; rat; fig 3
BioLegend ICOS antibody (BioLegend, C398.4A) was used in flow cytometry on rat samples (fig 3). Eur J Immunol (2015) ncbi
hamsters monoclonal (C398.4A)
BioLegend ICOS antibody (BioLegend, C398.4a) was used . J Immunol (2014) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; rhesus macaque; loading ...; fig s1c
In order to explore germinal center-related hyperimmune responses and disease severity during viral infection, BioLegend ICOS antibody (Biolegend, C398.4A) was used in flow cytometry on rhesus macaque samples (fig s1c). J Immunol (2014) ncbi
hamsters monoclonal (C398.4A)
  • flow cytometry; human; 1:100
BioLegend ICOS antibody (Biolegend, c398.4A) was used in flow cytometry on human samples at 1:100. J Clin Invest (2014) ncbi
Invitrogen
mouse monoclonal (ISA-3)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen ICOS antibody (eBioscience, ISA-3) was used in flow cytometry on human samples (fig 1a). Sci Adv (2021) ncbi
mouse monoclonal (ISA-3)
  • flow cytometry; human; loading ...; fig 3b
Invitrogen ICOS antibody (ThermoScientific, ISA-3) was used in flow cytometry on human samples (fig 3b). Acta Neuropathol (2021) ncbi
mouse monoclonal (ISA-3)
  • flow cytometry; human; loading ...; fig s2
Invitrogen ICOS antibody (eBioscience, ISA-3) was used in flow cytometry on human samples (fig s2). Aging Cell (2021) ncbi
mouse monoclonal (ISA-3)
  • flow cytometry; human; loading ...; fig 3b
Invitrogen ICOS antibody (ThermoFisher, 46-9948-42) was used in flow cytometry on human samples (fig 3b). Cell (2021) ncbi
mouse monoclonal (ISA-3)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen ICOS antibody (eBioscience, 17-9948-42) was used in flow cytometry on human samples (fig 1a). J Exp Med (2019) ncbi
mouse monoclonal (ISA-3)
  • flow cytometry; human; loading ...; fig s3
Invitrogen ICOS antibody (eBioscience, ISA-3) was used in flow cytometry on human samples (fig s3). Eur J Immunol (2019) ncbi
mouse monoclonal (ISA-3)
  • flow cytometry; human; loading ...; fig 3a
Invitrogen ICOS antibody (eBioscience, ISA-3) was used in flow cytometry on human samples (fig 3a). Cancer (2019) ncbi
domestic rabbit monoclonal (SP98)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 1Be
In order to measure programmed death-ligand 1 expression and immune checkpoints and assess their prognostic value for resected head and neck squamous cell cancer, Invitrogen ICOS antibody (Thermo Scientific, SP98) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1Be). Sci Rep (2016) ncbi
mouse monoclonal (ISA-3)
  • flow cytometry; human; loading ...; fig 4a
In order to characterize CD8 positive T cell subsets in dengue patients from India and Thailand, Invitrogen ICOS antibody (eBioscience, 46-9948-42) was used in flow cytometry on human samples (fig 4a). J Virol (2016) ncbi
mouse monoclonal (ISA-3)
  • blocking or activating experiments; human; 12.5 ug/ml; fig 6
Invitrogen ICOS antibody (eBioscience, 16-9948-82) was used in blocking or activating experiments on human samples at 12.5 ug/ml (fig 6). Oncoimmunology (2016) ncbi
mouse monoclonal (ISA-3)
  • flow cytometry; human; loading ...; fig 5a
Invitrogen ICOS antibody (eBiosciences, ISA-3) was used in flow cytometry on human samples (fig 5a). PLoS ONE (2016) ncbi
mouse monoclonal (ISA-3)
  • flow cytometry; human; loading ...; fig 2a
In order to demonstrate that TGF-beta induces the differentiation of human CXCL13-producing CD4 positive T cells from naive CD4 positive T cells, Invitrogen ICOS antibody (eBioscience, ISA-3) was used in flow cytometry on human samples (fig 2a). Eur J Immunol (2016) ncbi
mouse monoclonal (ISA-3)
  • flow cytometry; human; fig 1
Invitrogen ICOS antibody (eBioscience, 17-9948-41) was used in flow cytometry on human samples (fig 1). Clin Exp Immunol (2016) ncbi
mouse monoclonal (ISA-3)
  • flow cytometry; human; tbl 1
Invitrogen ICOS antibody (eBiosciences, cloneISA-3) was used in flow cytometry on human samples (tbl 1). J Gen Virol (2015) ncbi
mouse monoclonal (ISA-3)
  • flow cytometry; human
Invitrogen ICOS antibody (eBioscience, ISA-3) was used in flow cytometry on human samples . J Hepatol (2015) ncbi
mouse monoclonal (ISA-3)
  • flow cytometry; human
Invitrogen ICOS antibody (eBioscience, ISA-3) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (ISA-3)
  • flow cytometry; human
Invitrogen ICOS antibody (eBioscience, ISA-3) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (ISA-3)
  • flow cytometry; human
Invitrogen ICOS antibody (eBioscience, ISA3) was used in flow cytometry on human samples . Immunol Cell Biol (2014) ncbi
mouse monoclonal (ISA-3)
  • flow cytometry; human; fig 5
In order to identify immunologic correlates of immune reconstitution inflammatory syndrome in HIV patients, Invitrogen ICOS antibody (eBioscience, (clone ISA-3)) was used in flow cytometry on human samples (fig 5). Blood (2010) ncbi
mouse monoclonal (ISA-3)
  • flow cytometry; human; fig 3
In order to show that surface IL-17A is a marker for Th17 cells, Invitrogen ICOS antibody (eBioscience, ISA-3) was used in flow cytometry on human samples (fig 3). J Immunol (2009) ncbi
mouse monoclonal (ISA-3)
  • flow cytometry; human
Invitrogen ICOS antibody (eBioscience, ISA-3) was used in flow cytometry on human samples . J Immunol (2006) ncbi
BD Biosciences
mouse monoclonal (DX29)
  • flow cytometry; human; loading ...; fig s7d
BD Biosciences ICOS antibody (BD Biosciences, 563833) was used in flow cytometry on human samples (fig s7d). Cell (2019) ncbi
mouse monoclonal (DX29)
  • flow cytometry; human; loading ...; fig 3d
BD Biosciences ICOS antibody (BD Biosciences, DX29) was used in flow cytometry on human samples (fig 3d). J Exp Med (2018) ncbi
mouse monoclonal (DX29)
  • flow cytometry; human; loading ...; fig 2
BD Biosciences ICOS antibody (BD, DX29) was used in flow cytometry on human samples (fig 2). Biol Blood Marrow Transplant (2018) ncbi
mouse monoclonal (DX29)
  • flow cytometry; human; loading ...; fig 2
BD Biosciences ICOS antibody (BD Pharmingen, 557802) was used in flow cytometry on human samples (fig 2). Mol Med Rep (2017) ncbi
mouse monoclonal (DX29)
  • flow cytometry; human; loading ...; fig 6a
In order to define the contribution of CD103+ tumor-infiltrating lymphocytes to high-grade serous epithelial ovarian cancer, BD Biosciences ICOS antibody (BD Biosciences, DX29) was used in flow cytometry on human samples (fig 6a). Oncotarget (2016) ncbi
mouse monoclonal (DX29)
  • flow cytometry; human; fig 6
BD Biosciences ICOS antibody (BD Pharmigen, 557802) was used in flow cytometry on human samples (fig 6). Oncoimmunology (2016) ncbi
mouse monoclonal (DX29)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences ICOS antibody (BD, 557802) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (DX29)
  • flow cytometry; human; fig 1f
BD Biosciences ICOS antibody (BD Biosciences, DX29) was used in flow cytometry on human samples (fig 1f). PLoS Negl Trop Dis (2015) ncbi
mouse monoclonal (DX29)
  • flow cytometry; human
BD Biosciences ICOS antibody (BD, 557802) was used in flow cytometry on human samples . J Immunol Methods (2015) ncbi
mouse monoclonal (DX29)
  • flow cytometry; human
BD Biosciences ICOS antibody (BD Pharmingen, DX29) was used in flow cytometry on human samples . Clin Cancer Res (2014) ncbi
Articles Reviewed
  1. Horiuchi S, Wu H, Liu W, Schmitt N, Provot J, Liu Y, et al. Tox2 is required for the maintenance of GC TFH cells and the generation of memory TFH cells. Sci Adv. 2021;7:eabj1249 pubmed publisher
  2. Patial S, Lewis B, Vo T, Choudhary I, Paudel K, Mao Y, et al. Myeloid-IL4Rα is an indispensable link in IL-33-ILCs-IL-13-IL4Rα axis of eosinophil recruitment in murine lungs. Sci Rep. 2021;11:15465 pubmed publisher
  3. Zhang S, Li L, Xie D, Reddy S, Sleasman J, Ma L, et al. Regulation of Intrinsic and Bystander T Follicular Helper Cell Differentiation and Autoimmunity by Tsc1. Front Immunol. 2021;12:620437 pubmed publisher
  4. Lin X, Twelkmeyer T, Zhu D, Zhang L, Zhao Y, Zhang C, et al. Homeostatic regulation of T follicular helper and antibody response to particle antigens by IL-1Ra of medullary sinus macrophage origin. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  5. Ingelfinger F, Krishnarajah S, Kramer M, Utz S, Galli E, Lutz M, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141:901-915 pubmed publisher
  6. Sun Z, Yao Y, You M, Liu J, Guo W, Qi Z, et al. The kinase PDK1 is critical for promoting T follicular helper cell differentiation. elife. 2021;10: pubmed publisher
  7. Yang Y, Li X, Ma Z, Wang C, Yang Q, Byrne Steele M, et al. CTLA-4 expression by B-1a B cells is essential for immune tolerance. Nat Commun. 2021;12:525 pubmed publisher
  8. Webb L, Fra Bido S, Innocentin S, Matheson L, Attaf N, Bignon A, et al. Ageing promotes early T follicular helper cell differentiation by modulating expression of RBPJ. Aging Cell. 2021;20:e13295 pubmed publisher
  9. Rodda L, Netland J, Shehata L, Pruner K, Morawski P, Thouvenel C, et al. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Cell. 2021;184:169-183.e17 pubmed publisher
  10. Rundqvist H, Veliça P, Barbieri L, Gameiro P, Bargiela D, Gojkovic M, et al. Cytotoxic T-cells mediate exercise-induced reductions in tumor growth. elife. 2020;9: pubmed publisher
  11. Pasciuto E, Burton O, Roca C, Lagou V, Rajan W, Theys T, et al. Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell. 2020;182:625-640.e24 pubmed publisher
  12. Vacca F, Chauch C, Jamwal A, Hinchy E, Heieis G, Webster H, et al. A helminth-derived suppressor of ST2 blocks allergic responses. elife. 2020;9: pubmed publisher
  13. Pallikkuth S, Chaudhury S, Lu P, Pan L, Jongert E, Wille Reece U, et al. A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responses. elife. 2020;9: pubmed publisher
  14. Canel M, Taggart D, Sims A, Lonergan D, Waizenegger I, Serrels A. T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity. elife. 2020;9: pubmed publisher
  15. Schafflick D, Xu C, Hartlehnert M, Cole M, Schulte Mecklenbeck A, Lautwein T, et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat Commun. 2020;11:247 pubmed publisher
  16. Mantani P, Dunér P, Ljungcrantz I, Nilsson J, Bjorkbacka H, Fredrikson G. ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions. BMC Immunol. 2019;20:47 pubmed publisher
  17. Wang L, Shen E, Luo L, Rabe H, Wang Q, Yin J, et al. Control of Germinal Center Localization and Lineage Stability of Follicular Regulatory T Cells by the Blimp1 Transcription Factor. Cell Rep. 2019;29:1848-1861.e6 pubmed publisher
  18. Saliba D, Céspedes Donoso P, Balint S, Compeer E, Korobchevskaya K, Valvo S, et al. Composition and structure of synaptic ectosomes exporting antigen receptor linked to functional CD40 ligand from helper T cells. elife. 2019;8: pubmed publisher
  19. Di Blasi D, Boldanova T, Mori L, Terracciano L, Heim M, De Libero G. Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma. Cell Mol Gastroenterol Hepatol. 2020;9:195-218 pubmed publisher
  20. Hill D, Pierson W, Bolland D, Mkindi C, Carr E, Wang J, et al. The adjuvant GLA-SE promotes human Tfh cell expansion and emergence of public TCRβ clonotypes. J Exp Med. 2019;: pubmed publisher
  21. Mizuno R, Sugiura D, Shimizu K, Maruhashi T, Watada M, Okazaki I, et al. PD-1 Primarily Targets TCR Signal in the Inhibition of Functional T Cell Activation. Front Immunol. 2019;10:630 pubmed publisher
  22. Sugiura D, Maruhashi T, Okazaki I, Shimizu K, Maeda T, Takemoto T, et al. Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses. Science. 2019;364:558-566 pubmed publisher
  23. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  24. Binnewies M, Mujal A, Pollack J, Combes A, Hardison E, Barry K, et al. Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity. Cell. 2019;177:556-571.e16 pubmed publisher
  25. Qian L, Bajana S, Georgescu C, Peng V, Wang H, Adrianto I, et al. Suppression of ILC2 differentiation from committed T cell precursors by E protein transcription factors. J Exp Med. 2019;216:884-899 pubmed publisher
  26. Remmerswaal E, Hombrink P, Nota B, Pircher H, ten Berge I, van Lier R, et al. Expression of IL-7Rα and KLRG1 defines functionally distinct CD8+ T-cell populations in humans. Eur J Immunol. 2019;49:694-708 pubmed publisher
  27. Bath N, Ding X, Wilson N, Verhoven B, Boldt B, Sukhwal A, et al. Desensitization and treatment with APRIL/BLyS blockade in rodent kidney transplant model. PLoS ONE. 2019;14:e0211865 pubmed publisher
  28. Kobayashi T, Voisin B, Kim D, Kennedy E, Jo J, Shih H, et al. Homeostatic Control of Sebaceous Glands by Innate Lymphoid Cells Regulates Commensal Bacteria Equilibrium. Cell. 2019;176:982-997.e16 pubmed publisher
  29. Williams P, Basu S, Garcia Manero G, Hourigan C, Oetjen K, Cortes J, et al. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer. 2019;125:1470-1481 pubmed publisher
  30. Shi J, Hou S, Fang Q, Liu X, Liu X, Qi H. PD-1 Controls Follicular T Helper Cell Positioning and Function. Immunity. 2018;49:264-274.e4 pubmed publisher
  31. Zhang C, Wang C, Jiang M, Gu C, Xiao J, Chen X, et al. Act1 is a negative regulator in T and B cells via direct inhibition of STAT3. Nat Commun. 2018;9:2745 pubmed publisher
  32. Moysi E, Pallikkuth S, de Armas L, Gonzalez L, Ambrozak D, George V, et al. Altered immune cell follicular dynamics in HIV infection following influenza vaccination. J Clin Invest. 2018;128:3171-3185 pubmed publisher
  33. Sayin I, Radtke A, Vella L, Jin W, Wherry E, Buggert M, et al. Spatial distribution and function of T follicular regulatory cells in human lymph nodes. J Exp Med. 2018;215:1531-1542 pubmed publisher
  34. Hutten T, Norde W, Woestenenk R, Wang R, Maas F, Kester M, et al. Increased Coexpression of PD-1, TIGIT, and KLRG-1 on Tumor-Reactive CD8+ T Cells During Relapse after Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2018;24:666-677 pubmed publisher
  35. Yi W, Gupta S, Ricker E, Manni M, Jessberger R, Chinenov Y, et al. The mTORC1-4E-BP-eIF4E axis controls de novo Bcl6 protein synthesis in T cells and systemic autoimmunity. Nat Commun. 2017;8:254 pubmed publisher
  36. Minutti C, Jackson Jones L, Garcia Fojeda B, Knipper J, Sutherland T, Logan N, et al. Local amplifiers of IL-4R?-mediated macrophage activation promote repair in lung and liver. Science. 2017;356:1076-1080 pubmed publisher
  37. Lu X, Horner J, Paul E, Shang X, Troncoso P, Deng P, et al. Effective combinatorial immunotherapy for castration-resistant prostate cancer. Nature. 2017;543:728-732 pubmed publisher
  38. Martin Gayo E, Cronin J, Hickman T, Ouyang Z, Lindqvist M, Kolb K, et al. Circulating CXCR5+CXCR3+PD-1lo Tfh-like cells in HIV-1 controllers with neutralizing antibody breadth. JCI Insight. 2017;2:e89574 pubmed publisher
  39. Shan Y, Qi C, Liu Y, Gao H, Zhao D, Jiang Y. Increased frequency of peripheral blood follicular helper T cells and elevated serum IL?21 levels in patients with knee osteoarthritis. Mol Med Rep. 2017;15:1095-1102 pubmed publisher
  40. Kinosada H, Yasunaga J, Shimura K, Miyazato P, Onishi C, Iyoda T, et al. HTLV-1 bZIP Factor Enhances T-Cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors. PLoS Pathog. 2017;13:e1006120 pubmed publisher
  41. Kim H, Ha S, Hong M, Heo S, Koh Y, Choi E, et al. PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients. Sci Rep. 2016;6:36956 pubmed publisher
  42. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  43. Chandele A, Sewatanon J, Gunisetty S, Singla M, Onlamoon N, Akondy R, et al. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India. J Virol. 2016;90:11259-11278 pubmed
  44. Ramirez Carrozzi V, Sambandam A, Zhou M, Yan D, Kang J, Wu X, et al. Combined blockade of the IL-13 and IL-33 pathways leads to a greater inhibition of type 2 inflammation over inhibition of either pathway alone. J Allergy Clin Immunol. 2017;139:705-708.e6 pubmed publisher
  45. Johnston L, Hsu C, Krier Burris R, Chhiba K, Chien K, McKenzie A, et al. IL-33 Precedes IL-5 in Regulating Eosinophil Commitment and Is Required for Eosinophil Homeostasis. J Immunol. 2016;197:3445-3453 pubmed
  46. Komdeur F, Wouters M, Workel H, Tijans A, Terwindt A, Brunekreeft K, et al. CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy. Oncotarget. 2016;7:75130-75144 pubmed publisher
  47. Lexmond W, Goettel J, Lyons J, Jacobse J, Deken M, Lawrence M, et al. FOXP3+ Tregs require WASP to restrain Th2-mediated food allergy. J Clin Invest. 2016;126:4030-4044 pubmed publisher
  48. Leong Y, Chen Y, Ong H, Wu D, Man K, Deléage C, et al. CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat Immunol. 2016;17:1187-96 pubmed publisher
  49. Franzese O, Palermo B, Di Donna C, Sperduti I, Ferraresi V, Stabile H, et al. Polyfunctional Melan-A-specific tumor-reactive CD8(+) T cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS. Oncoimmunology. 2016;5:e1114203 pubmed publisher
  50. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed publisher
  51. Bal S, Bernink J, Nagasawa M, Groot J, Shikhagaie M, Golebski K, et al. IL-1?, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat Immunol. 2016;17:636-45 pubmed publisher
  52. Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed publisher
  53. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  54. Leeth C, Racine J, Chapman H, Arpa B, Carrillo J, Carrascal J, et al. B-lymphocytes expressing an Ig specificity recognizing the pancreatic ß-cell autoantigen peripherin are potent contributors to type 1 diabetes development in NOD mice. Diabetes. 2016;65:1977-1987 pubmed publisher
  55. Llibre A, López Macías C, Marafioti T, Mehta H, Partridge A, Kanzig C, et al. LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation. J Immunol. 2016;196:2085-94 pubmed publisher
  56. Li L, Jiang Y, Lao S, Yang B, Yu S, Zhang Y, et al. Mycobacterium tuberculosis-Specific IL-21+IFN-γ+CD4+ T Cells Are Regulated by IL-12. PLoS ONE. 2016;11:e0147356 pubmed publisher
  57. Vargas Inchaustegui D, Demers A, Shaw J, Kang G, Ball D, Tuero I, et al. Vaccine Induction of Lymph Node-Resident Simian Immunodeficiency Virus Env-Specific T Follicular Helper Cells in Rhesus Macaques. J Immunol. 2016;196:1700-10 pubmed publisher
  58. Kobayashi S, Watanabe T, Suzuki R, Furu M, Ito H, Ito J, et al. TGF-β induces the differentiation of human CXCL13-producing CD4(+) T cells. Eur J Immunol. 2016;46:360-71 pubmed publisher
  59. Kim J, Phan T, Nguyen V, Dinh Vu H, Zheng J, Yun M, et al. Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. Theranostics. 2015;5:1328-42 pubmed publisher
  60. Miles B, Miller S, Folkvord J, Kimball A, Chamanian M, Meditz A, et al. Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection. Nat Commun. 2015;6:8608 pubmed publisher
  61. Sakthivel P, Grunewald J, Eklund A, Bruder D, Wahlström J. Pulmonary sarcoidosis is associated with high-level inducible co-stimulator (ICOS) expression on lung regulatory T cells--possible implications for the ICOS/ICOS-ligand axis in disease course and resolution. Clin Exp Immunol. 2016;183:294-306 pubmed publisher
  62. Chen X, Li W, Zhang Y, Song X, Xu L, Xu Z, et al. Distribution of Peripheral Memory T Follicular Helper Cells in Patients with Schistosomiasis Japonica. PLoS Negl Trop Dis. 2015;9:e0004015 pubmed publisher
  63. Lu K, Keppler S, Leithäuser F, Mattfeldt T, Castello A, Kostezka U, et al. Nck adaptor proteins modulate differentiation and effector function of T cells. J Leukoc Biol. 2015;98:301-11 pubmed publisher
  64. Vettermann C, Victor H, Sun Y, Plewa C, Gupta S. A signaling-enhanced chimeric receptor to activate the ICOS pathway in T cells. J Immunol Methods. 2015;424:14-9 pubmed publisher
  65. Nelson M, Kundimi S, Bowers J, Rogers C, Huff L, Schwartz K, et al. The inducible costimulator augments Tc17 cell responses to self and tumor tissue. J Immunol. 2015;194:1737-47 pubmed publisher
  66. Xie L, Choudhury G, Winters A, Yang S, Jin K. Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10. Eur J Immunol. 2015;45:180-91 pubmed publisher
  67. Gerna G, Lilleri D, Fornara C, Bruno F, Gabanti E, Cane I, et al. Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host. J Gen Virol. 2015;96:360-9 pubmed publisher
  68. Spaan M, Kreefft K, de Graav G, Brouwer W, de Knegt R, ten Kate F, et al. CD4+ CXCR5+ T cells in chronic HCV infection produce less IL-21, yet are efficient at supporting B cell responses. J Hepatol. 2015;62:303-10 pubmed publisher
  69. Cucak H, Vistisen D, Witte D, Philipsen A, Rosendahl A. Reduction of specific circulating lymphocyte populations with metabolic risk factors in patients at risk to develop type 2 diabetes. PLoS ONE. 2014;9:e107140 pubmed publisher
  70. Herati R, Reuter M, Dolfi D, Mansfield K, Aung H, Badwan O, et al. Circulating CXCR5+PD-1+ response predicts influenza vaccine antibody responses in young adults but not elderly adults. J Immunol. 2014;193:3528-37 pubmed publisher
  71. Ohue Y, Kurose K, Mizote Y, Matsumoto H, Nishio Y, Isobe M, et al. Prolongation of overall survival in advanced lung adenocarcinoma patients with the XAGE1 (GAGED2a) antibody. Clin Cancer Res. 2014;20:5052-63 pubmed publisher
  72. Hong J, Amancha P, Rogers K, Courtney C, Havenar Daughton C, Crotty S, et al. Early lymphoid responses and germinal center formation correlate with lower viral load set points and better prognosis of simian immunodeficiency virus infection. J Immunol. 2014;193:797-806 pubmed publisher
  73. Bedke T, Iannitti R, De Luca A, Giovannini G, Fallarino F, Berges C, et al. Distinct and complementary roles for Aspergillus fumigatus-specific Tr1 and Foxp3+ regulatory T cells in humans and mice. Immunol Cell Biol. 2014;92:659-70 pubmed publisher
  74. Gros A, Robbins P, Yao X, Li Y, Turcotte S, Tran E, et al. PD-1 identifies the patient-specific CD8? tumor-reactive repertoire infiltrating human tumors. J Clin Invest. 2014;124:2246-59 pubmed publisher
  75. Antonelli L, Mahnke Y, Hodge J, Porter B, Barber D, DerSimonian R, et al. Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome. Blood. 2010;116:3818-27 pubmed publisher
  76. Brucklacher Waldert V, Steinbach K, Lioznov M, Kolster M, Holscher C, Tolosa E. Phenotypical characterization of human Th17 cells unambiguously identified by surface IL-17A expression. J Immunol. 2009;183:5494-501 pubmed publisher
  77. Quiroga M, Pasquinelli V, Martinez G, Jurado J, Zorrilla L, Musella R, et al. Inducible costimulator: a modulator of IFN-gamma production in human tuberculosis. J Immunol. 2006;176:5965-74 pubmed